The Effect of Urtica dioica L. On Glucose and Lipid Indexes in Diabetic Patients
Phase 3
- Conditions
- Non-insulin-dependent diabetes mellitusdiabetic mellitus type2.
- Registration Number
- IRCT2015010720594N1
- Lead Sponsor
- Imam Hussein Shahrood Hospital Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 108
Inclusion Criteria
Inclusion criteria : age over 30 years; HbA1c less than 10 %; the most common diabetes medications ( Metformin ?Glibenclamide )
Exclusion criteria : a history of cardiovascular disease; renal disease; infectious disease; liver disease; thyroid disease; allergies disease; angina disease; consumption of nonsteroidal antiinflammatory drugs (NSAIDs); consumption of warfarin; consumption of estrogen and progesterone drugs; smoking, consumption of dietary supplements; consumption of herbal decoction; pregnancy and lactation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c. Timepoint: After three month. Method of measurement: Blood Sampling.;HDL. Timepoint: After three month. Method of measurement: Blood Sampling.;LDL. Timepoint: After three month. Method of measurement: Blood sampling.;TG. Timepoint: After three month. Method of measurement: Blood Sampling.;FBS. Timepoint: After three month. Method of measurement: Blood Sampling.;BS2pp. Timepoint: after three month. Method of measurement: blood sampling.;Cholesterol. Timepoint: After three month. Method of measurement: Blood Sampling.
- Secondary Outcome Measures
Name Time Method Body mass index. Timepoint: The baseline. Method of measurement: Meter?Balance.;Systolic Blood Pressur. Timepoint: first and last Undertaking Study. Method of measurement: Barometer.;Dyastolic Blood Pressure. Timepoint: First and last Undertaking Study. Method of measurement: Barometer.